World’s first dengue vaccine approved in Mexico
09-Dec-15, Sanofi Pasteur
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the Mexican authorities have granted marketing authorization to Dengvaxia®, making it the first vaccine to be licensed in the world for the prevention of dengue.
%20See%20And%20Say.png "Worlds first dengue vaccine approved in Mexico (c) See And Say")
Image: See And Say
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has approved Dengvaxia®, tetravalent dengue vaccine, for the prevention of disease caused by all four dengue virus serotypes in preadolescents, adolescents and adults, 9 to 45 years of age living in endemic areas.